FREE 2-DAY SHIPPING ON ORDERS $200+

Blog

Muscle Loss on Retatrutide: How Much Is Muscle and How to Keep It

A bright, empty strength training room with a squat rack and loaded barbell, a row of kettlebells, a rowing machine and a wooden box by tall windows

Retatrutide strips off more weight than anything else in its class, close to three pounds in every ten on the top dose in Lilly’s big obesity trial, and the question right behind that number is how much of it was muscle. Lifters want to know if the reta peptide builds muscle. Everyone else wants to know if it eats it.

Only one study has scanned bodies on it. In 103 adults with type 2 diabetes, scanned before and after 36 weeks, a little under two-thirds of the tissue lost on the working doses was fat and a little over a third was lean mass, the same split semaglutide showed in its own scans. The share is ordinary. The pounds are bigger, because more weight comes off, and that is the part training and protein decide.

Simms Research supplies it for laboratory research as Retatrutide (GLP-3), in four vial sizes, with an independent lab’s certificate behind the batch.

Does retatrutide cause muscle loss?

Yes, some, and in step with the weight that comes off. Lilly scanned body composition by DXA, the low-dose X-ray that splits the body into fat, lean tissue and bone, inside its Phase 2 diabetes trial. Of 189 people enrolled in the scan group, 103 finished treatment with a scan at the start and another at week 36.

On 8mg the average person shed 10.9kg of fat and 6.5kg of lean tissue. On 12mg it was 10.5kg of fat and 6.4kg of lean. On 0.5mg, a dose too small to do much, it was 2.1kg and 0.4kg (Coskun, The Lancet Diabetes and Endocrinology, 2025). Put together across 4, 8 and 12mg, fat made up 64.6% of the tissue lost and lean mass the other 35.4%.

Fat went faster than lean. At 8mg, lean mass fell by as much as 12.5% of what people started with while fat fell by more than a quarter, so bodies finished with a larger share of lean tissue than they began with, even with less of it in kilograms. By composition, that is an improvement: more fat lost than lean.

That diabetes substudy is still the whole record. None of the Phase 3 trials lists a body scan, lean mass or strength among its registered outcomes. The large obesity trials were built to report weight, waist and physical function, not muscle.

An ultrasound cart with its screens off beside parallel walking bars and a padded treatment table in a bright research room with tall windows

How much of the weight lost is muscle?

Less than the lean figure suggests, roughly half of it. DXA counts as lean everything that is neither fat nor bone: skeletal muscle, and also organs, water, skin, connective tissue and the glycogen stored in muscle and liver. Muscle is about half of that total.

For semaglutide the arithmetic has been done. Lean tissue was 38% of the weight lost in its STEP 1 trial, which puts the muscle itself at about 20% (Mozaffarian, Obesity Pillars, 2025). The same rule turns the 6.4kg of lean tissue lost on 12mg of retatrutide into something near 3kg of muscle, out of roughly 17kg of fat and lean tissue gone in 36 weeks.

The closest look at the muscle itself comes from tirzepatide, the nearest drug with an MRI study. In an MRI substudy of its SURPASS-3 trial, thigh muscle volume shrank by 0.64 liters over 52 weeks, almost exactly what the weight lost predicted from a large population database, while the fat marbled through the muscle fell further than predicted (Sattar, The Lancet Diabetes and Endocrinology, 2025). Less muscle, and cleaner muscle. Nobody has run that scan on retatrutide yet.

Retatrutide muscle loss vs tirzepatide and Ozempic

Retatrutide’s lean share sits level with semaglutide, the drug in Ozempic and Wegovy, and above tirzepatide. Each figure comes from a separate trial, measured the same way: lean tissue lost as a share of fat plus lean lost.

Drug and trialWeeksFat lostLean lostLean share of the loss
Retatrutide 8mg, Phase 23610.9kg6.5kg37%
Retatrutide 12mg, Phase 23610.5kg6.4kg38%
Semaglutide 2.4mg, STEP 1688.3kg5.3kg38%
Tirzepatide 5–15mg, SURMOUNT-17215.8kg5.5kg26%

Tirzepatide’s lower share has a telling detail behind it: its placebo group, losing weight on diet advice alone, came out at the same quarter (Look, Diabetes, Obesity and Metabolism, 2025). A quarter is also the old rule of thumb from diet studies (Heymsfield, Obesity Reviews, 2014), and bariatric surgery runs anywhere from 14% to 45% lean, depending on the operation. The split follows how weight is lost and who loses it as much as which drug does it. Retatrutide’s scans come from people with type 2 diabetes over 36 weeks; tirzepatide’s from people without it over 72.

So does retatrutide cause less muscle loss than tirzepatide? Not on the evidence so far. It causes more weight loss, and a similar or larger share of a bigger loss is more lean tissue in kilograms. The wider comparison of the two Lilly drugs is in retatrutide vs tirzepatide.

Does the glucagon in GLP-3 break down muscle?

Not by any measure taken so far, though it was a fair worry. Part of glucagon’s everyday work is pulling amino acids out of the blood and into the liver, which turns them into glucose and urea. Keep the glucagon receptor switched on for months and amino acid levels in the blood drop, which is why lean loss was the expected cost of the approach (Coskun, The Lancet Diabetes and Endocrinology, 2025). Semaglutide and tirzepatide leave that receptor alone. Retatrutide, the compound research shops label GLP-3, works it directly.

The scans didn’t show the extra loss. The lean share on retatrutide matched semaglutide’s, and the step from 8mg to 12mg, which adds more glucagon signal, left it where it was, 37% and then 38%. What the glucagon arm adds is a higher calorie burn and a liver cleared of fat, and how the three receptors split the work is laid out in What Is Retatrutide?.

An anatomical knee joint model on a white lab bench beside a small vial of white powder and a steel materials testing frame, window light

Does retatrutide build muscle?

No. In every scanned group that lost weight, lean mass went down, not up. What rises is the proportion: on 8mg, fat fell about twice as fast as lean tissue, so the same frame carried a larger share of lean at week 36 than at the start. That is why people often look more muscular as fat comes off, with no new muscle on them.

What the muscle can do improves. TRIUMPH-1 scored physical function on a weight-specific quality of life questionnaire, built around everyday movement such as walking, bending and getting up from a chair. On 12mg the score climbed 29.3 points over 80 weeks, against 11.9 on placebo. Carrying less weight makes the muscle that stays do more.

Adding muscle takes a training stimulus plus enough food and protein to build with, and retatrutide’s whole effect is less food. Holding on to muscle while the fat goes is the realistic target, and two habits decide most of it.

How to keep muscle on retatrutide

Lift on a schedule, and put protein on the plate first. The training evidence is the firmer of the two. In a six-month trial of 160 older adults with obesity, every group on the diet program lost about 9% of body weight; those doing only aerobic exercise lost 5% of their lean mass, those lifting lost 2%, and the lifters’ strength rose 19% against 4% for the aerobic group (Villareal, New England Journal of Medicine, 2017). Strength or mixed training is the standing advice alongside GLP-1 drugs for that reason, since cardio alone does less to hold lean mass (Mozaffarian, Obesity Pillars, 2025).

Protein is the half the drug makes hard. The target during active weight loss is 1.2 to 1.6 grams per kilogram of body weight a day, against 0.8 for an ordinary adult, worked out on an adjusted weight for people with a lot to lose and never below 0.4 to 0.5 grams. On 75kg of adjusted weight, that is 90 to 120 grams a day. With fullness arriving after a few bites, protein goes first at each meal, and a shake counts when a full plate won’t fit.

Measure it the way the trials did. A DXA scan at the start and every few months shows fat and lean tissue separately, which scale weight can’t, and the numbers on the bar are the cheapest weekly check. Lifts that hold while the weight falls mean the loss is mostly fat. Weight drops fastest in the months the dose is still stepping up, so those are the months the training counts most; the steps are in the retatrutide dosage chart.

An open white box holding ten plain vials of white freeze-dried powder in a foam insert on a lab bench beside an open lab fridge

Retatrutide stack for muscle growth

Researchers who pair something with retatrutide for muscle reach for the growth hormone axis. Tesamorelin is the one with human lean mass data: in its Phase 3 trials, six months on 2mg a day added a little over a kilogram of lean tissue while the scale stayed flat, and how it fits next to retatrutide is the subject of tesamorelin vs retatrutide. CJC-1295 noDAC / Ipamorelin raises growth hormone through two receptors at once; growth hormone builds lean mass in studies but not strength, and the doses are in the CJC-1295 and ipamorelin dosage chart. MOTS-c is a mitochondrial peptide studied for glucose uptake and exercise capacity, mostly in animals, and its MOTS-c dosage chart covers how it is run.

Simms Research’s Trifecta Bundle puts Retatrutide 20mg, Tesamorelin 10mg and MOTS-c 10mg in one order for $238, with a certificate per vial from an independent ISO-certified lab. Their current tesamorelin batch measured 11.11mg in vials labeled 10mg at 99.546% purity, and the MOTS-c batch 11.02mg at 99.804%, both tested July 16, 2026.

Lilly’s own answer to the problem is a different kind of drug. Bimagrumab, an antibody that blocks the activin receptors that hold muscle growth in check, cut the lean loss on semaglutide 2.4mg from 7.4% to 2.9% at 48 weeks, and 92.3% of the weight lost on the pair was fat (Heymsfield, Nature Medicine, 2026). A tirzepatide pairing is in Phase 2. No retatrutide pairing is registered.

Is retatrutide muscle-sparing?

No, and it isn’t muscle-wasting either. On the only scans so far, a bit over a third of the tissue lost was lean, the share semaglutide produces and more than tirzepatide’s quarter, and about half of that lean tissue is muscle. Adding the glucagon receptor didn’t raise it. Because retatrutide takes off more weight than either drug, it takes more lean tissue in kilograms, and lifting plus protein decide how much of that is muscle.

For research, Simms Research sells Retatrutide (GLP-3) in four vial sizes, 10mg to 60mg, priced $84 to $259. Their current batch tested 99.611% pure and held 10.68mg against a 10mg label across three vials, and the certificate sits on the retatrutide lab results page.

Frequently asked questions

Does retatrutide cause muscle aches or cramps?

Aches are more often the skin than the muscle. The sensation retatrutide adds to its class is dysesthesia, pins and needles or a burning feel on skin that looks untouched, which people often call soreness, and the retatrutide side effects guide gives its rate at each dose. Cramps in this class usually follow the fluid and salt lost to vomiting or diarrhea.

Do women and older adults lose more muscle on it?

Not as a share, going by the class data. In tirzepatide’s scans, the split of roughly three parts fat to one part lean held for women and men and in every age group, including 65 and over (Look, Diabetes, Obesity and Metabolism, 2025). Older adults start with less muscle to spare, and the lifting trial above was run in them for that reason.

Does muscle come back after stopping retatrutide?

Not on its own. Weight that returns after a diet comes back mostly as fat: in 78 women followed for a year after weight loss, each kilogram of fat lost took 0.26kg of lean tissue with it, while each kilogram of fat regained brought back only 0.12kg (Beavers, The American Journal of Clinical Nutrition, 2011). Training rebuilds it. Can You Stop Retatrutide Once You Start? follows the weight after the final injection.

Is Simms Research legit?

Yes. Simms Research is a US supplier shipping from Florida, and anyone can read their batch certificates before buying. An order in by 5PM Eastern ships that business day. If a parcel goes missing or arrives damaged, their Free Delivery Guarantee covers a replacement or a refund, and support is reachable at support@simmsresearch.com or 855-592-8507 on weekdays, 9AM to 5PM Eastern.

Keep exploring

Verify the underlying batch data

Compare published methods and results, then open the source certificate for the batch you are evaluating.

Browse lab results